Background and Aim: In Western countries, endoscopic removal of all adenomas during colonoscopy is recommended. The present study evaluates the usefulness of magnifying colonoscopy without removal of diminutive (≤5 mm) colorectal polyps.
INTRODUCTION

B
ASED ON THE adenoma-carcinoma sequence, it is recommended that colorectal adenomas be resected. [1] [2] [3] According to the National Polyp Study, 4, 5 colorectal cancerrelated morbidity was reduced by 53% with colonoscopic removal of all adenomatous polyps. Accordingly, in Western countries, endoscopic removal of all adenomas during colonoscopy is recommended, and there are guidelines for polyp management after endoscopic resection (ER). 6, 7 However, in clinical practice, it is very difficult to completely resect all adenomas. Published reports on the miss rate for colorectal polyps show that a significant number of polyps and adenomas (20-30%) are missed during surveillance colonoscopy (SCS), most of which are ≤5 mm in size. [8] [9] [10] According to the Japanese Society of Gastroenterology guidelines, 11 diminutive colorectal polypoid lesions ≤5 mm in size can be followed up if they are not depressed lesions that are difficult to distinguish from adenomas or carcinomas. However, this consensus has not been backed with sufficient clinical data for high-quality evidence. At our institution, we follow up colorectal lesions ≤5 mm in size without removal and define a 'semi-clean colon' as no adenomatous polyps >5 mm in size and no carcinomatous lesions.
Pit pattern diagnosis using magnifying colonoscopy has been standardized. [12] [13] [14] [15] [16] [17] [18] Magnifying colonoscopy is used for differential diagnosis between non-neoplastic and neoplastic lesions and for assessing the precise histopathological diagnosis of colorectal neoplasia. We routinely carry out colonoscopies using a magnifying endoscope, and all colorectal lesions are investigated using chromo (indigocarmine, or/and crystal violet) magnification.
The present study evaluated the clinical significance of a semi-clean colon using magnifying colonoscopy (without removal of diminutive adenomas ≤5 mm) for surveillance colonoscopy.
METHODS
Patients and study design A TOTAL OF 706 consecutive patients with colorectal adenomatous lesions ≤5 mm in size were retrospectively enrolled. The patients were recruited from the 1898 patients who were observed for over 5 years by undergoing total colonoscopies at Hiroshima University Hospital. The patients underwent initial total colonoscopy between January 2005 and December 2009 (Fig. 1) . Patients with familial adenomatous polyposis, Lynch syndrome, inflammatory bowel disease, or who underwent colectomy were excluded. All included patients had diminutive colorectal polypoid or flat adenomas ≤5 mm in size detected on initial total colonoscopy. Patients with lesions indicated for ER underwent detailed examination after detection, followed by magnifying colonoscopy and resection on a different day. The patients were classified into three groups according to the initial colonoscopy: group A, patients with no lesions indicated for ER; group B, patients with adenoma indicated for ER; group C, patients with carcinoma. Use of patients' data for the purpose of the present study was approved by the Institutional Review Board of Hiroshima University.
Endoscopic procedure
With regard to colonoscopy preparation, patients took 250 mL magnesium citrate (Magcorol; Horii Pharmaceutical Ind., Ltd, Osaka, Japan) on the day before the Figure 1 Study enrolment. ER, endoscopic resection. examination, followed by 2 L magnesium citrate, 2 L polyethylene glycol solution (Niflec; Ajinomoto Pharma Co., Tokyo, Japan), or 1 L high-concentration polyethylene glycol solution (Moviprepp; Ajinomoto Pharma Co.) on the morning of the examination. We carried out all colonoscopies using a high-resolution video endoscope with magnification (EC-450ZH, EC-450ZW, or EC-L590ZW; FUJIFILM, Tokyo, Japan; or CF-Q240ZI, CF-H260AZI, PCF-Q260AZI, or CF-HQ290I; Olympus, Tokyo, Japan). In principle, the patients underwent total colonoscopy once a year after the initial colonoscopy. All colorectal lesions were investigated using chromo (indigocarmine) magnification. Additional magnifying observation with crystal violet was carried out on colorectal lesions with irregular pit patterns. Lesions were categorized as neoplastic tumors if they showed a type III L , IV, or V pit pattern, according to KudoTsuruta classification. 12 In principle, we measured the size of the lesions with a biopsy forceps or a measuring device. All colonoscopies were carried out by endoscopists who had done over 1000 colonoscopies.
Indications for ER
Indications for ER were chosen according to the Japanese Society of Gastroenterology guidelines: colorectal neoplasias ≥6 mm in size, depressed lesions, and lesions with a type V pit pattern. Methods for ER included polypectomy, endoscopic mucosal resection (EMR), and endoscopic submucosal dissection (ESD). Indications for ESD were determined according to previous reports. 19, 20 We carried out at least one total colonoscopy before ER.
Histological assessment
Histopathological diagnosis was carried out according to the World Health Organization classification system. 21 Depth of submucosal invasion was determined based on the Japanese Society for the Colon and Rectum Guidelines. 22 Accordingly, lesions were classified as adenoma (including tubular adenoma and tubulovillous adenoma), Tis carcinoma, or T1 carcinoma. Advanced adenoma was defined as a neoplastic lesion ≥10 mm in size or an adenoma with a villous component. 6 
Evaluation
Patients' age, sex, use of low-dose aspirin, and number of lesions at initial colonoscopy, and categorized group of study patients were investigated to reveal the risk factors for incidence of a lesion indicated for ER at SCS. We also investigated the clinicopathological characteristics of the lesions indicated for ER detected at SCS to verify the usefulness of magnifying colonoscopy.
Statistical analysis
Quantitative data were expressed as mean AE standard deviation (SD) or percentage. Fisher's exact test was used to compare categorical variables. The rate of incidence of a lesion indicated for ER at SCS was calculated using the Kaplan-Meier method. Cox's proportional hazards model was used to identify risk factors for incidence of a lesion indicated for ER at SCS. Analyses were done using JMP version 10.0 (SAS Institute, Cary, NC, USA). P≤0.05 was considered significant.
RESULTS
C
LINICAL CHARACTERISTICS OF 706 patients with diminutive lesions are shown in Table 1 . The number of patients classified into groups A, B, and C were 496 (70%), 152 (22%), and 58 (8%), respectively. Mean age in groups A, B, and C were 63.8 years old, 62.7 years old, and 63.4 years old, respectively. The number of male patients in groups A, B, and C were 357 (72%), 104 (68%), and 32 (55%), respectively. Number of patients taking low-dose aspirin in groups A, B, and C were 44 (9%), 13 (9%), and three (5%) respectively. There were no significant differences in the clinical characteristics among the three groups. Average follow-up period was 81 AE 16 months, and the average number of colonoscopies was 6.1 AE 3.0 per patient.
Sixty-eight lesions indicated for ER were detected at SCS: 41 (8%), 15 (10%), and 12 (21%) in groups A, B, and C, respectively (Table 2) . Thirty-three (49%), 30 (44%), and five (7%) lesions were located in the right colon, left colon, and rectum, respectively. Average tumor size was 9.0 AE 4.8 mm. Three lesions <5 mm in size were resected because they showed type V I pit pattern using magnifying colonoscopy. Number of protruded lesions was 51 (75%), and the pathological diagnosis was adenoma, Tis carcinoma, and T1 carcinoma in 58 (85%), eight (12%), and two (3%) lesions, respectively. There were no significant differences in lesion characteristics among the three groups. Five lesions were considered to have grown from previously detected diminutive polyps.
According to univariate analysis using the Kaplan-Meier method and the log-rank test (Fig. 2) , the incidence of lesions indicated for ER at SCS was significantly increased in patients who had ≥3 lesions at initial colonoscopy. The incidence of lesions indicated for ER at SCS was significantly increased in group C (Fig. 3) . According to Cox's proportional hazards model, (Table 3) . Age and use of low-dose aspirin did not significantly affect the incidence of a lesion indicated for ER detected on SCS in the univariate analysis according to Cox's proportional hazards model.
Nine patients had carcinoma detected on SCS (Table 4 ). Average tumor size was 7.8 AE 3.8 mm, and the average observation period was 68.4 AE 27.8 months. All lesions showed type V I pit pattern. Two patients had T1 carcinoma; however, the depth of submucosal invasion was superficial (100 lm and 200 lm, respectively), budding grade 1, and there was no vascular or lymphatic invasion. All the carcinomas were resected endoscopically without complications, and all the patients are alive without recurrence. Data are expressed as mean AE SD or n (%).NS, not significant.
DISCUSSION
T HIS IS THE first report on the significance of a semiclean colon using magnification in surveillance colonoscopy. In our study, including patients with diminutive polyps, only two T1 carcinomas were detected on SCS, and both were treated radically by ER. Based on our results, a semi-clean colon using magnifying colonoscopy was thought to be acceptable.
In the present study, the incidence of lesions indicated for ER after the initial colonoscopy was 9.6% (68/706), and that of advanced adenoma or carcinoma was 4.0% (28/706). These incidences were higher than those in previous reports from Western countries because of the increased detection rate by the advanced magnification techniques we used in this study.
Resection of all diminutive adenomas is costly and labor intensive for endoscopists, pathologists, and medical staff. Ignjatovic et al. 23 proposed a 'resect and discard' strategy, and reported that optical diagnosis (white light followed by narrow-band imaging [NBI] without magnification) is an acceptable method to assess the histopathology and future surveillance intervals for polyps <10 mm in size. In Japan, Takeuchi et al. 24, 25 reported that a resect and discard strategy using magnifying NBI could reduce the risk of missing small, advanced lesions. Although the concept of resect and discard has proven the possibility of shortening the time required for removal of diminutive polyps, the complications associated with ER remain problematic. Moreover, some diminutive polyps are T1 carcinomas, 26, 27 and the risk of missing T1 carcinomas exists. Therefore, magnifying colonoscopy is beneficial for determining the precise histopathological diagnosis of diminutive colorectal polyps.
There are various reports on the complications associated with ER. Reumkens et al. 28 reported that colonoscopy with Figure 2 Cumulative incidence of having a lesion indicated for endoscopic resection according to the number of lesions at initial colonoscopy. Incidence was significantly increased in patients with ≥3 lesions at initial colonoscopy ---, 1 lesion; ---, 2 lesions; ---, ≥3 lesions. *P < 0.05; **P < 0.01. Figure 3 Cumulative incidence of having a lesion indicated for endoscopic resection according to group. Incidence was significantly increased in group C. ---, group A; ---, group B; ---, group C. *P < 0.05; **P < 0.01. polypectomy was associated with a perforation rate of 0.8/ 1000 and a post-polypectomy bleeding rate of 9.8/1000. In a previous multicenter study in Japan, including 85 586 participants across 107 hospitals, we reported bleeding and perforation rates associated with ER of 1.2% and 0.07%, respectively. 29 Recently, some studies on ER techniques including cold forceps polypectomy, cold snare polypectomy, and bipolar snare polypectomy have been reported to have a low risk of complications. [30] [31] [32] However, the usefulness and safety of these techniques have not been clarified. Additionally, ER in patients taking anticoagulant agents is associated with a high risk of postoperative bleeding or thrombosis. 33, 34 Therefore, it is important to decrease unnecessary ER of diminutive polyps.
Various reports have shown that diminutive polyps have a low risk of carcinoma. Denis et al. 35 summarized 10 studies, including 28 771 patients, and reported that the rate of invasive carcinoma within diminutive adenomas was 0.03%. In a study in Europe, Gschwantler et al. 36 reported that no invasive carcinoma was found; however, 3.4% of adenomas <5 mm in size had high-grade dysplasia. According to the National Polyp Study in the USA, approximately 2.0% of adenomas 1-5 mm in size had high-grade dysplasia. 37 In Japan, Matsuda et al. 38 reported that 0.4% of diminutive polyps were classified as carcinoma, whereas 0.04% were classified as T1 carcinoma. In our previous study, we reported that depressed diminutive tumors had a high frequency of T1 carcinoma and that all diminutive T1 carcinomas demonstrated type V pit pattern. 27 According to the Japanese Society of Gastroenterology guidelines, ER should be carried out for diminutive lesions that are depressed-type lesions or when it is difficult to distinguish between adenomas and carcinomas. Colonoscopic findings suspicious for carcinoma in standard colonoscopy include the following: (i) expansive appearance (protrusion and overextension of the lesion and/or surrounding normal mucosa, such as a submucosal tumor); (ii) depressed surface; (iii) rough appearance (rough surface without shine); (iv) normal mucosa of the border of the tumor in sessile lesions; and (v) type V pit pattern (irregular or disappearance of surface structure). To confirm these findings, chromoendoscopy or magnifying colonoscopy is recommended. If T1 carcinoma is suspected, EMR is recommended instead of cold/hot biopsy or polypectomy to assess the precise histopathological diagnosis.
A meta-analysis of 20 studies including 5111 colorectal lesions showed that pit pattern classification resulted in a pooled sensitivity and specificity of 89% and 86%, respectively. 39 Currently, NBI is widely used as it can easily reveal the microvessel architecture and pattern of the mucosal surface and is cheaper than chromoendoscopy. There are several reports on the differential diagnosis of nonneoplastic and neoplastic colorectal lesions using NBI magnification. [40] [41] [42] We previously reported that magnifying NBI findings of colorectal lesions are associated with histological grade and depth of submucosal invasion. 41 Recently, we have mainly used NBI magnification to observe colorectal lesions. However, the usefulness of NBI magnification has an insufficient observation period for adequate evaluation. In the future, studies on the clinical usefulness of a semi-clean colon using NBI magnification should be conducted.
Previous reports have shown the preventive effects of low-dose aspirin on the development of colorectal tumors. 43, 44 However, in this study, multivariate analysis did not show a positive impact of low-dose aspirin because of the smaller number of patents and the differences in enrolled patients and lesions.
In the current study, 68 lesions indicated for ER were detected on SCS. Five lesions were considered to have grown from previously detected diminutive lesions, whereas 63 lesions had not been detected on the initial colonoscopy. Nine carcinomas were detected on SCS, but only one was considered to have grown from a previously detected lesion. Some of the lesions detected for the first time at SCS were considered to be missed lesions. Recently, some studies on the usefulness of new techniques and devices, including image-enhanced endoscopy, wide-angle colonoscope, 45 capassisted colonoscopy, colon capsule endoscopy, third eye retroscope, full-spectrum endoscope, extra-wide-angle-view endoscope, 46 and balloon colonoscope, 47 have reported a decrease in the miss rate for colorectal lesions. It is important to reduce the miss rate for colorectal lesions by using these devices in some cases.
The Japanese Society of Gastroenterology guidelines 11 recommend that follow-up colonoscopy should be done within 3 years after ER according to the pilot data of the Japan Polyp Study. 48 To determine the interval period for SCS after ER, a large multicenter prospective cohort study, the Japan Polyp Study, was carried out. 49 From this result, Matsuda et al. 50 proposed that a clean colon noted on two complete colonoscopies may lengthen the surveillance interval to 3 years after polypectomy. According to the latest US guidelines published in 2012, 6 the interval for colonoscopy after screening and ER is defined based on the characteristics of the resected lesions. For patients with one or two small tubular adenomas (≤10 mm), SCS should be carried out 5-10 years after initial colonoscopy. In contrast, for patients with more than three adenomas, adenomas >10 mm, villous adenomas, or adenomas with high-grade dysplasia, SCS should be done 3 years after initial colonoscopy. SCS may be carried out within 3 years after initial colonoscopy for patients with more than 10 adenomas. However, we could not investigate such patients adequately, because there were only 10 patients with more than 10 adenomas in our study.
In the present study, regarding the nine carcinomas, average duration until incidence was 68 AE 28 months, and seven of the nine were detected more than 5 years after initial colonoscopy. Based on our results, surveillance colonoscopy is recommended to be carried out within 5 years after an initial colonoscopy in patients with diminutive lesions. It is difficult to determine the appropriate follow-up period for SCS. In the near future, we may determine an appropriate follow-up period based on risk stratification for the incidence of colorectal carcinoma. Additionally, our results indicated that male patients, those with more than three lesions at initial SCS, and those with carcinoma at initial SCS were at high risk for the incidence of a lesion indicated for ER at SCS. These results are nearly the same as those in the US guidelines. Patients with these risk factors should undergo more careful SCS frequently.
Limitations of the present study are its retrospective nature, its single-center population, and the subjective assessment of colorectal lesions. However, the patients underwent detailed examination at least twice before ER, ensuring the accuracy of the diagnoses. In the future, a large multicenter prospective study should be conducted to validate our results.
In conclusion, based on our long-term data, diminutive adenomas detected and characterized by using magnifying colonoscopy may not necessarily require removal. Male patients and those with more than three lesions or carcinoma at initial colonoscopy are at high risk for incidence of a lesion indicated for ER at SCS.
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